Fact CheckerSign in

NCT03932903Recruiting

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Using Real Time Mobile Health Approaches to Understand and Promote Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Source: ClinicalTrials.gov · Last updated 30 Jun 2026

Brief summary (registry, in English)

This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
24 Apr 2019
Start date
31 Jul 2025
Primary completion date
31 Jul 2027
Lead sponsor
Northwestern University
NCT number
NCT03932903

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 31 Jul 2025 to the primary completion date, 31 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • AYA Inclusion Criteria:
  • Ages 14-29
  • Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
  • In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
  • Prescribed 6-mercaptopurine (6MP)
  • English language proficiency
  • For AYA \<18, must have informed consent from their caregiver.
    • AYA Exclusion Criteria:
  • Cognitive impairments that would limit ability to complete measures, determined by the medical team
  • Absence of inclusion criteria above.
    • Caregiver Inclusion Criteria:
  • Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
  • English language proficiency
    • Caregiver Exclusion Criteria:
    • \- Absence of inclusion criteria above.

Age in the registry: 14 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Robert H Lurie Comprehensive Cancer Center Northwestern University
Coordinator of this site? Confirm its status		ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.